• Trelagliptin Succinate: Experimental Workflows in Diabetes R

  2026-07-17

  Trelagliptin succinate (SYR-472 succinate) stands out as a long-acting, selective DPP-4 inhibitor tailored for advanced type 2 diabetes research. Its unique pathway modulation and robust performance in metabolic, inflammatory, and bone biology assays streamline both in vitro and in vivo experimental design.

• Adefovir (GS-0393): Optimizing HBV Antiviral Workflows in Re

  2026-07-17

  Adefovir (GS-0393) stands out as a dual-purpose tool for hepatitis B virus research and renal transporter studies, offering unmatched selectivity for HBV DNA polymerase alongside robust pharmacokinetic characterization. This article delivers protocol-level guidance, troubleshooting strategies, and insights from recent literature to maximize experimental reproducibility and translational relevance.

• Canagliflozin Reshapes Renal Mitochondria in Hypertensive–Di

  2026-07-16

  This study demonstrates that canagliflozin, a selective SGLT2 inhibitor, not only normalizes albuminuria but also remodels mitochondrial structure and function in proximal tubular cells of hypertensive–diabetic mice. These findings provide mechanistic insight into the kidney-protective effects of SGLT2 inhibitors beyond glycemic control, with implications for future diabetes and renal research.

• Structure-Based Identification of NSP15 Inhibitors for SARS-

  2026-07-16

  This study pioneers a structure-based virtual screening approach to identify natural product inhibitors of SARS-CoV-2 NSP15, a viral endoribonuclease implicated in immune evasion. The discovery of thymopentin and oleuropein as potent, stable NSP15 binders highlights a promising antiviral strategy and provides a platform for further translational research.

• Viperin Disrupts Coronavirus Replication via nsp8 and ddhCTP

  2026-07-15

  This study uncovers a dual antiviral mechanism by which viperin inhibits coronavirus replication: direct interference with the viral replication-transcription complex via binding to non-structural protein 8 (nsp8), and enzymatic production of ddhCTP, a nucleotide analog that terminates viral RNA synthesis in susceptible coronaviruses. These findings provide a molecular basis for broad-spectrum RNA virus replication inhibition and highlight new targets for antiviral drug development.

• Polygodial and TRPA1: Decoding Ion Channel Signaling in Sens

  2026-07-15

  Explore the multifaceted role of Polygodial as a TRPA1 channel activator in sensory ion channel research. This article offers an in-depth, evidence-based perspective on molecular mechanisms, translational assay design, and new frontiers in neuroepithelial signaling.

• Applied Workflows with BGJ398 (NVP-BGJ398) in FGFR Research

  2026-07-14

  BGJ398 (NVP-BGJ398) sets the benchmark for selective FGFR targeting, enabling high-confidence dissection of FGFR-driven malignancies and developmental pathways. Discover protocol refinements, troubleshooting strategies, and key translational insights for maximizing success in oncology research and organogenesis models.

• Spermine as a Precision Tool: Decoding Polyamine Regulation

  2026-07-14

  Explore how spermine, a pivotal endogenous polyamine, uniquely regulates membrane excitability and nuclear envelope dynamics in eukaryotic cells. This article provides advanced insight into spermine’s mechanistic role, its practical impact on cellular assays, and how new discoveries in nuclear membrane fusion redefine ion channel research.

• Anagliptin-Induced Vasorelaxation: Roles of Kv Channels and

  2026-07-13

  The 2025 Acta Diabetologica study provides the first direct mechanistic evidence that Anagliptin (SK-0403) induces vasorelaxation in rabbit aorta via activation of voltage-dependent K+ (Kv) channels and SERCA pump, independent of endothelium or classical cAMP/cGMP pathways. These findings clarify vascular actions of this DPP-4 inhibitor, informing research design in diabetes and cardiovascular disease.

• Anagliptin (SK-0403): Protocols for Vascular and DPP-4 Resea

  2026-07-13

  Anagliptin (SK-0403) bridges DPP-4 inhibition with direct vascular modulation, enabling advanced workflows for diabetes and cardiovascular research. This guide translates the latest mechanistic insights into practical protocols, troubleshooting, and assay design.

• Canagliflozin as an SGLT2 Inhibitor: Optimizing Renal Resear

  2026-07-12

  Canagliflozin empowers translational diabetes and nephrology research by enabling precise SGLT2 inhibition and revealing mitochondrial mechanisms underlying kidney protection. This article delivers actionable protocol guidance, troubleshooting strategies, and a data-driven synthesis of recent mitochondrial findings for advanced metabolic disease studies.

• Moesin as a Biomarker of Endothelial Injury in Sepsis: Evide

  2026-07-10

  The referenced study identifies moesin as a novel biomarker that reflects endothelial injury severity in sepsis. By linking increased serum moesin to disrupted vascular integrity and inflammatory signaling, the research offers new mechanistic insights and experimental opportunities for sepsis and cardiovascular studies.

• Adipose-Neural Axis Drives Cardiac Arrhythmias via Leptin-NP

  2026-07-09

  Fan et al. reveal that the adipose-neural axis mechanistically links epicardial adipose tissue to cardiac arrhythmias through leptin and neuropeptide Y (NPY) signaling. Their stem cell-based coculture model uncovers new molecular targets and provides a foundation for therapeutic interventions in arrhythmia.

• ATP in Translational Strategy: Beyond Energy to Enzyme Contr

  2026-07-09

  Adenosine triphosphate (ATP) is universally recognized as the cell's primary energy carrier, yet its roles transcend bioenergetics—encompassing direct signaling and nuanced regulation of mitochondrial metabolism. This thought-leadership piece synthesizes mechanistic discoveries, such as TCAIM-mediated post-translational control of the TCA cycle, with strategic guidance for translational researchers. We elucidate how leveraging high-purity ATP from APExBIO (SKU C6931) can elevate cellular metabolism research, enable advanced purinergic receptor studies, and unlock new investigative frontiers in disease modeling.

• 5-(N,N-dimethyl)-Amiloride Hydrochloride: Unraveling Endothe

  2026-07-08

  Explore the unique role of 5-(N,N-dimethyl)-Amiloride hydrochloride in dissecting intracellular pH regulation and endothelial function during sepsis. This in-depth analysis advances beyond standard protocols to reveal how targeted inhibition of Na+/H+ exchangers refines experimental modeling and biomarker discovery.

15891 records 1/1060 page Next 12345 下5页 Last page